Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Randomized Phase II Study of an Appetite Stimulant, Cyproheptadine Hydrochloride, With and Without a Nutritional Supplement, in Children With Cancer/Treatment-Related Weight Loss

NCT00949117 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT00949117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00949117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Randomized Phase II Study of an Appetite Stimulant, Cyproheptadine Hydrochloride, With and Without a Nutritional Supplement, in Children With Cancer/Treatment-Related Weight Loss
Lead sponsor
University of South Florida
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2009
Completion date
November 30, 2011
Enrollment
9 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma, malnutrition, myelodysplastic syndromes, unspecified childhood solid tumor, protocol specific, weight changes